HOME


    2009 Senior Symposium Program
          

 

                   To access these PDF files you must have Adobe Reader installed on your computer.
                 
If you do not have this application, it may downloaded at no charge by clicking on the Adobe icon
             

 

Thursday, April 23rd  

 11:30am  Registration Opens  Location: Pre-Function 1

12:00 noon - 1:30 pm
Opening Remarks:
Learning Lab with Lunch: Lexapro for Depression
This non-CE event is supported by Forest Laboratories Inc.

Speaker:
Robert B. Santulli, M.D.

Location: Premier A/C

 

1:45 am - 3:45 pm  LAW CE

Multidisciplinary Session:  A How-To Guide for Earning a Five-Star Rating for your Home - OIG and Public Health in LTC
Program #009-999-09-003-L03-P   0.20 CEU (2 contact hours)

 

Speaker: Janet Williams, R.N.& Barbara Cass, R.N.
            
& Tom Coffey, R.N., BSN

Location: Premier E/F

 

Learning Objectives

• Describe the Quality Indicator Survey (QIS) process

• Outline strategies and examples of continuous quality
  improvement (CQI) projects to prepare for the QIS survey

• Describe long-term care through the eyes of the Department of
  Public Health (DPH) inspectors

• Review DPH policies and regulations as they pertain to practice
  in LTC

• Explain what DPH inspectors are looking for and how to avoid
  deficiencies by staying current

• Identify areas of improvement for compliance with DPH policies and
  regulations in LTC

 

  download handout (Coffey)

download handout (Cass)

      download handout (Williams)

3:45pm - 4:00 pm Break
4:00 pm - 4:45 pm
CONNDONA QUARTERLY MEETING::
Understanding the 5 Star Quality Rating
**
This is a nursing/NP CE activity; No pharmacist CE will be offered

 

Speaker: Stephen T. Surprenant

Location: Premier H

1.    

Learning Objectives

• Participants will understand the method used to calculate the
  CMS 5 Star Quality Rating

•
Participants will understand the various metrics used by CMS to
  create the ratings in each area

• Participants will discuss strategies to positively impact future
  5 Star ratings

 


download handout

4:00 pm - 4:45 pm
ASCP - CT Chapter: Board of Directors Monthly Meeting
Transition of Officers & Awards

 

Location: Premier G
 
 


 

Please note: Cocktail & Dinner Events Below

4:45 pm - 6:00 pm
Toolkit for Prevention, Treatment and Monitoring
of Influenza
This is a non-CE event with cocktails & hors d'oeuvres
 

Speaker: Tom Clark, RPh
Location: Premier B/D

 

5:45 pm - 6:30 pm
Dinner & Opening Remarks
Location: Premier A/C

 

6:30 pm - 7:30 pm

Dementia: What To Do With the Progressively
Declining Patient
Program #009-999-09-004-L04-P   0.10 CEU (1 contact hour)
Supported by an unrestricted educational grant from Forest Laboratories Inc.

Speaker:
Robert B. Santulli, M.D.
Location: Premier A/C
 

Learning Objectives

• Compare various mental status exams, their strengths and
  weaknesses, and overall utility in tracking Alzheimer’s disease
  (AD) progression

• Describe current treatment options for AD and identify monitoring
  parameters for efficacy and toxicity of current therapies

• Identify promising therapies in development for the future
  treatment of AD patients

• Describe how to manage behavioral problems given recent
  warnings concerning antipsychotic medications in the elderly


                        download handout
 

Friday, April 24th
6:00 am
Registration Opens  Location: Pre-Function 1
6:00 am - 7:00 am
Breakfast - First Lite Symposium Attendees Only

Location: Premier B/D

7:00 am - 8:00 am
First Lite Symposium
A Case Study in Chronic Constipation: Diagnosis & Treatment in Long-Term Care Residents
Program #203-999-08-070-L01-P   0.10 CEU (1 contact hour)


Supported by an educational grant from Sucampo
Pharmaceuticals, Inc., and Takeda Pharmaceuticals
North America, Inc.

Speaker: Michael Brodeur, PharmD, GCP, FASCP

Location: Premier A/C

Learning Objectives

• Access the impact of chronic constipation in the elderly as it
  relates to quality of life, psychological effects and healthcare
  economics

• Describe ways to tailor management strategies and treatment
  plans for the various etiologies of chronic constipation often
  encountered in residents of long-term care, including
  medication-related causes

• Evaluate the role of traditional and newer pharmacologic
  treatment options for chronic constipation in elderly patients
  with various comorbid conditions

• Apply principles of an interdisciplinary approach to monitor
  treatment progress and to assess the efficacy of chronic
  constipation therapies in elderly patients
 

8:00 am
Break
- Coffee Provided
Location: Pre-Function 2

 

8:15 am
Opening Remarks
Location: Premier A/C

 

8:30 am - 10:00 am
Opening General Session I
New Drugs Update
Program #009-999-09-005-L01-P   0.15 CEU (1.5 contact hours)

Speaker: Tom Frank, PharmD
Location: Premier A/C

Learning Objectives

• Explain new trends in drug development

• List indications, pharmacology, adverse effects and dosing of the
  products discussed

• Describe the role these products will play in clinical practice

• Describe the economic implications of these choices

• Identify products in the short-term pipeline that will be important
  to the practice of the participants


download handout

10:00 am

Break - Coffee Provided
Location: Pre-Function 2

10:15 am - 11:15am
Second General Session
6th Annual Timothy Webster Memorial Address:
The Road to Living to 100: Smooth Sailing and Obstacles

Program #009-999-09-006-L04-P   0.10 CEU (1 contact hour)

Speaker: Thomas T. Perls, MD, MPH, FACP
Location: Premier A/C


Learning Objectives

• Explain the demography of aging and exceptional
   longevity
•
Identify factors conducive to healthy aging and exceptional
  longevity

•
Describe the anti-aging industry and quackery

 

download handout

 

11:15 am - 2:00 pm
Lunch / Exhibit Hall

Location: Premier B/D

 

12:45 pm - 1:45 pm

Management of Behavior and Aggression in Older
Demented Patients
Program #009-999-09-007-L04-P   0.10 CEU (1 contact hour)
 

Speaker: Phil Wizwer, PharmD
Location: Premier A/C

Learning Objectives

• Identify why “demented” elderly may become “agitated”

• Identify why psychoactive agents are inappropriately  utilized in
  the older population

• Identify medications that should be avoided in cognitively
  impaired seniors

• Identify ways to manage behavioral problems with and without
  medications

• Identify approaches to modifying behavior without the use of
  medications

PRE-REGISTRATION REQUIRED:

Registration for this session is now closed
The seating limit has been reached

 

download handout

LEARNING LABS - Dessert Provided

 

1:15 pm - 1:45 pm
Learning Lab: Diagnosis and Management of COPD - A Treatable, Long-Term Progressive Disease
Presented by Boehringer-Ingelheim
This is a non-CE event
Speaker: F. Randy Vogenberg, MEd, PhD
Location: Premier E/F

 

1:15 pm - 1:45 pm
Learning Lab: Identifying and Managing PHN in Older Adults
Presented by Endo Pharmaceuticals 
This is a non-CE event
Speaker: Heather Thomson, MBA, MS
Location: Premier G


1:15 pm - 1:45 pm
Learning Lab: TBA
Presented by Watson Pharma
 This is a non-CE event
Speaker: TBA
Location: Premier H

 

1:15 pm - 1:45 pm
Learning Lab: Treating Osteoporosis in the Long-Term Care Setting
Presented by GlaxoSmithKline
Speaker: Lisa Venditti, RPh
Location: Bravo Theatre - Upper Level

 

2:00 pm - 3:00 pm
An Interdisciplinary
Approach to Appropriate Medication Usage
Program #009-999-09-008-L04-P
0.10 CEU (1 contact hour)


Speaker: Peg Weir, NP-C
Location: Premier H

Learning Objectives

• Recall the definition of polypharmacy

• Recall risk factors associated with
  polypharmacy

• Recall both in-patient and out-patient
  strategies to identify and reduce
  polypharmacy using a interdisciplinary
  approach that includes Pharmacists,
  Providers, Nutritionalists, Nurses, and of
  course patients.

• Recall the expanding role that Nurse
  Practitioners play in managing

  polypharmacy

 

download handout

2:00 pm - 3:00 pm
Pharmacogenomics & Patient Safety:
How This Emerging Science may Save Lives
Program #009-999-09-009-L05-P
0.10 CEU (1 contact hour)


Speaker: Megan Ehret, PharmD
Location: Premier E/F

Learning Objectives

• Recall the basics of pharmacogenomics and
  its role in patient safety

• Identify genetic risk factors for serious
  adverse drug reactions in the elderly
  population

• Produce a checklist for evaluating the
  potential role of pharmacogenomics in
  elderly patient safety

 

download handout  

2:00 pm - 3:00 pm
Restless Nights and Drowsy Days: Sleep-Wake Disturbances in Older Persons
Program #009-999-09-016-L04-P
0.10 CEU (1 contact hour)

 

Speaker: Carlos Fragoso, M.D.
Location: Premier G

Learning Objectives

• State the prevalence of insomnia
  symptoms and napping among older
  persons

• Describe the predisposing, precipitating
  and perpetuating factors that underlie
  sleep-wake disturbances among older
  persons

• Describe at least five
  non-pharmacological interventions that
  improve sleep quality and/or daytime
  alertness among older persons.

 

download handout C

ecticut

 

3:00 pm Break  
    Location: Pre-Function 2
 
3:15 pm - 4:15 pm
Management of Dyslipidemia in the Elderly: Is it to Late to Help?

Program #009-999-09-011-L01-P
0.10 CEU (1 contact hour)

Speakers: Wen-Chih (Hank) Wu, M.D.
Location: Premier H

Learning Objectives

• Recall recent data regarding the safety
  of cholesterol lowering agents

• Define guidelines for managing
  hyperlipidemia in the elderly

• Identify reasons for appropriately
  discontinuing cholesterol therapy in the
  elderly

download handout

3:15 pm - 4:15 pm  LAW CE
Pharmacy law: Legislation Update & Pharmacy Inspection Walkthrough
Program #009-999-09-012-L03-P
0.10 CEU (1 contact hour)


Speaker: John Gadea, Jr., RPh
Location: Premier E/F

Learning Objectives

• Explain current Connecticut state
  legislation under review as it pertains to
  the practice of pharmacy

• Describe what to expect in a standard
  pharmacy inspection by a Drug Control
  Agent

 

download handout

3:15 pm - 4:15 pm

Suicide in the Elderly
Supported by an educational grant from Lilly USA, LLC.
Program #009-999-09-013-L04-P
0.10 CEU (1 contact hour)


Speakers: Charley Caley, PharmD
Location: Premier G

Learning Objectives

• Identify the risk factors of suicide in the
  elderly

• Describe what the optimal treatment of
  depression in elderly patients is

• Define response vs. remission in
  depression and describe the importance
  of achieving remission in elderly patients
  with depression

• Identify patient centered activities that
  pharmacists can practice that begin to
  proactively diminish suicide risk in
  the elderly

 

download handout

 

4:15 pm Break -Coffee Provided
    Location: Pre-Function 2
 
4:30 pm - 5:30 pm
Diabetes Jeopardy
Program #009-999-09-014-L04-P 
0.10 CEU (1 contact hour)


Speakers: Jennifer Lee, PharmD
Location: Premier H

Learning Objectives

• Review treatment goals in older adult
  patients with diabetes
o

• Discuss pharmacologic considerations
  for blood glucose control in older adults
• Discuss the treatment options in the
  prevention and management of
  diabetes-related complications



 

4:30 pm - 5:30 pm  LAW CE
Pharmacy Law: An Overview of Prescription Monitoring Program (PMP) and Appropriate Drug Disposal
Program #009-999-09-015-L03-P 
0.10 CEU (1 contact hour)


Speakers: John Gadea, Jr., RPh
                Xaviel Soto
Location: Premier E/F

Learning Objectives

• Describe the Prescription Monitoring
  Program (PMP) and define its role in
  pharmacy practice

• Describe appropriate drug disposal
  through review of completed or planned
  programs in the state

 

download handout o

4:30 pm - 5:30 pm

COPD: Deflating the Overinflated
Program #009-999-09-010-L01-P
0.10 CEU (1 contact hour)


Speaker: Sean Jeffery, PharmD
Location: Premier G

Learning Objectives

• Define the role of pulmonary rehab in
  improving quality of life for COPD
  patients

• Identify strategies to maximize exercise
  tolerance through the use of approved
  pharmacotherapy

• Explain complications associated with
  end-stage COPD and their management
 


download handout


 

 

Copyright © 2004 CTASCP